(Q40896263)

English

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

based on heuristic

inferred from title

author name string

G Ragupathi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

M Meyers

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

S Adluri

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

L Howard

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

C Musselli

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

P O Livingston

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

659-666

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones. Markers for gliomas and neuroblastomas.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Carbohydrate antigens as targets for active specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Different reactivities of monoclonal antibodies to ganglioside lactones

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Cell-surface antigens of melanoma recognized by human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C659%3A%3AAID-IJC11%3E3.0.CO%3B2-5

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(20000301)85:5<659::AID-IJC11>3.0.CO;2-5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40896263&oldid=1614766806"